IRIS
GORACCI, ARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.388
NA - Nord America 6.035
AS - Asia 1.273
SA - Sud America 143
AF - Africa 43
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.910
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.005
RU - Federazione Russa 2.283
GB - Regno Unito 1.710
IT - Italia 1.598
IE - Irlanda 853
CN - Cina 631
SE - Svezia 468
UA - Ucraina 438
SG - Singapore 417
FR - Francia 243
DE - Germania 228
FI - Finlandia 155
PL - Polonia 136
BR - Brasile 124
ES - Italia 105
JP - Giappone 53
VN - Vietnam 53
NL - Olanda 51
HK - Hong Kong 24
CH - Svizzera 23
AU - Australia 22
CA - Canada 22
IN - India 20
TR - Turchia 19
BE - Belgio 18
IR - Iran 15
CI - Costa d'Avorio 13
AT - Austria 12
GR - Grecia 9
PT - Portogallo 9
CZ - Repubblica Ceca 8
HU - Ungheria 7
IQ - Iraq 6
MX - Messico 6
NG - Nigeria 6
PK - Pakistan 6
RO - Romania 6
EG - Egitto 5
UG - Uganda 5
UY - Uruguay 5
CL - Cile 4
DK - Danimarca 4
EC - Ecuador 4
KE - Kenya 4
KR - Corea 4
MA - Marocco 4
AR - Argentina 3
EU - Europa 3
KZ - Kazakistan 3
LU - Lussemburgo 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
AL - Albania 2
BD - Bangladesh 2
BG - Bulgaria 2
DZ - Algeria 2
KG - Kirghizistan 2
LT - Lituania 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
PE - Perù 2
PH - Filippine 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HR - Croazia 1
JM - Giamaica 1
LK - Sri Lanka 1
MD - Moldavia 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
TH - Thailandia 1
TJ - Tagikistan 1
TM - Turkmenistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 15.910
Salva come PNG Salva come JPEG
Città #
Southend 1.609
Dublin 844
Fairfield 748
Ashburn 608
Houston 574
Chandler 475
Santa Clara 380
Woodbridge 372
Jacksonville 349
Seattle 282
Wilmington 275
Cambridge 245
Ann Arbor 208
Siena 168
Princeton 150
Singapore 150
Beijing 148
Nanjing 107
Rome 95
Málaga 90
Helsinki 88
Milan 88
Florence 70
San Mateo 70
Boardman 60
Washington 59
Dong Ket 52
Nanchang 43
San Diego 42
Moscow 41
Tianjin 36
Menlo Park 35
Warsaw 30
Norwalk 28
Shenyang 28
Council Bluffs 27
New York 26
Dallas 24
Hebei 23
Dearborn 22
Jiaxing 19
Bologna 18
Brussels 18
London 18
Los Angeles 17
Prato 17
Kunming 16
Naples 16
Trento 16
Fremont 15
Jinan 15
Redwood City 15
Brescia 14
Changsha 14
Palermo 14
Abidjan 13
Guangzhou 13
Hong Kong 13
Cagliari 12
Latina 12
Mestre 12
San Francisco 12
The Dalles 12
Zhengzhou 12
Düsseldorf 11
Hefei 11
Shanghai 11
Nuremberg 10
São Paulo 10
Toronto 10
Turin 10
Verona 10
Genoa 9
Ningbo 9
Siapiccia 9
Sinalunga 9
Venezia 9
Vienna 9
Catania 8
Curitiba 8
Genova 8
Krakow 8
Livorno 8
Padova 8
Torino 8
Bari 7
Lodz 7
Melbourne 7
Pescara 7
Wroclaw 7
Będzin 6
Chicago 6
Falkenstein 6
Lanzhou 6
Messina 6
Montebelluna 6
Mugnano di Napoli 6
Napoli 6
Paris 6
Parma 6
Totale 9.410
Salva come PNG Salva come JPEG
Nome #
Questionnaire for the Assessment of Quality of Life in Healthy Subjects (VQV-ss): Elaboration of a new instrument for the assessment of quality of life in the general population [Questionario per la Valutazione della Qualità della Vita nei soggetti sani (VQV-ss): Elaborazione di un nuovo strumento per l'assessment della Qualità della Vita nella popolazione generale] 2.532
Clinical effectiveness of parenteral trazodone for the management of psychomotor activation in patients with bipolar disorder 437
Internet Addiction Disorder in a Sample of 402 High School Students [Zespół uzależnienia od internetu w grupie 402 uczniów szkoły ̈redniej] 325
Antidepressants in healthy subjects: what are the psychotropic/psychological effects? 317
Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice 292
Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder 260
The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia 232
Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice 226
P.2.f.022 Psychiatric disorder and sexual dysfunction: a pilot study 220
P.5.f.010 Evaluation of the treatment of elderly agitated patients:a preliminary study 215
P.1.k.027 Autoerotic and sexual activity in psychiatric patients 214
Mood stabilisers and pregnancy outcomes - a review 198
Personal resources and depression in schizophrenia: the role of self-esteem, resilience and internalized stigma 194
The Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and Review 193
Mood disorders and bariatric surgery: a pilot study 185
Le diverse espressioni dell'ansia e della paura: per iniziare a comprendere il mondo di coloro che soffrono di disturbi d'ansia 185
Liraglutide in psychiatric patients: preliminary results 184
Telepsychiatry: new perspectives and open issues 181
P.1.k.034 Psychomotor agitation in emergency medicine settings 177
Drug safety evaluation of aripiprazole in bipolar disorder 170
null 169
P.8.b.006 Binge eating disorder and bariatric surgery: a pilot study 169
Early warning symptoms of schizophrenia 168
Prevalence and correlates of Vitamin D deficiency in a sample of 290 inpatients with mental illness 168
Italian Study on Depressive Disorders (STudio Italiano MAlattia Depressiva, or STIMA-D): A Nationwide Snapshot of the Status of Treatment for Major Depression 167
One month weight loss predicts the efficacy of liraglutide in obese patients: Data from a single center 166
Quality of life, anxiety and depression in Sarcoidosis 165
Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice 164
Feasibility, adherence and efficacy of liraglutide treatment in a sample of individuals with mood disorders and obesity 162
null 155
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 155
Impulsiveness and psychiatric disorders: a transnosographic comparison among 179 psychiatric inpatients 150
Panic agoraphobic spectrum in psychiatrically healthy subjects: impact on quality of life 150
Total aripiprazole dosage: Setting up the method on the cobas® 8000 analyzer [Dosaggio dell’aripiprazolo totale: messa a punto del metodo su analizzatore Cobas 8000] 150
Hypofunctioning of sensory gating mechanisms in patients with obsessive-compulsive disorder. 149
Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice 146
Uno studio pilota sulla concentrazione plasmatica di aripiprazolo. 144
The effects of undertreated chronic medical illnesses in patients with severe mental disorders 143
Quality of life and sub threshold affective symptoms 140
Pathways to functional outcome in subjects with schizophrenia living in the community and their unaffected first-degree relatives 140
Correlazione tra concentrazione plasmatica, efficacia e tollerabilità in un gruppo di pazienti trattati con aripiprazolo. 140
Quality of life and subthreshold obsessive-compulsive disorder 139
Confini tra disturbo ossessivo-compulsivo e depressione: Considerazioni psicopatologiche 139
Social cognition in people with schizophrenia: a cluster-analytic approach 139
Social phobia spectrum and social phobic behaviours spectrum [Lo spettro della fobia sociale e lo spettro dei comportamenti fobico-sociali] 139
Advances in treatment for postpartum major depressive disorder 138
Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder 135
null 134
Infertility and psychiatric morbidity 134
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 131
Pharmacotherapy of binge-eating disorder: a review 129
The long term-maximising potential for rehabilitation in patients with schizophrenia 128
Quetiapine in post-transplant acute mania/bipolar disorder NOS 127
L' impatto della psicopatologia affettiva (sia conclamata che sottosoglia) sulla qualità della vita 126
Mood spectrum symptoms during a major depressive episode: Differences between 145 patients with bipolar disorder and 155 patients with major depressive disorder. Arguments for a dimensional approach 126
Affective temperaments and subthreshold symptoms spectrum in a clinical sample [Temperamenti affettivi e spettri di psicopatologia sottosoglia in un campione di popolazione clinica] 124
Trazodone Contramid® in clinical practice: personalizing antidepressant intervention 123
Clinica della mania 122
Spettro dell'umore e sindrome metabolica 120
Possible involvement of opioid systems in obsessive-compulsive disorder: Psychopathological considerations [Possibile coinvolgimento del sistema oppioide nel disturbo ossessivo-compulsivo e relative considerazioni psicopatologiche] 120
Transnosography of aggressiveness, a psychopathological dimension of mania [Aspetti transnosografici dell'aggressività, una delle dimensioni psicopatologiche della mania] 120
Obsessive-compulsive disorder and quality of life outcomes: Protocol for a systematic review and meta-analysis of cross-sectional case-control studies 119
Psychopharmacological treatment and personality: Cognitive schemes changes during pharmacological treatments [Psicofarmaci e personalitá: Modificazioni degli schemi cognitivi in corso di trattamenti farmacologici] 117
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 116
The asthenia issue in obsessive-compulsive disorder [II problema della astenia nel disturbo ossessivo-compulsivo] 115
Endocrine and metabolic effects of medications used for bipolar disorder [Effetti endocrini e metabolici dei farmaci utilizzati nel disturbo bipolare] 114
What can we learn from the large US Cohort study (STEP-BD) 110
null 106
Per una ricerca della nuclearità maniacale al di là delle dimensioni psicopatologiche 104
null 100
S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): A clinician-oriented systematic review 100
Effectiveness of light therapy as adjunctive treatment in bipolar depression: A pilot study 100
Dimensional nosography of anxiety and mood disorders: The impact on quality of life [Nosografia dimensionale dei disturbi d'ansia e dell'umore: I'impatto sulla qualità di vita] 99
Physical activity and mental health, psychological and physiological mechanisms 99
Relationship of non-suicidal self-injury and suicide attempt: a psychopathological perspective 97
Psicopatologia della mania: dimensioni fenomenologiche 96
A new approach for seasonal pattern: is it related to bipolarity dimension? Findings from an Italian multicenter study 93
Quality of life and sensory threshold: Study in a sample of healthy subjects [Qualità della vita e fenomenica sottosoglia: Studio in un campione di soggetti sani] 88
Human CRY1 variants associate with attention deficit/hyperactivity disorder 83
Benefici e potenziali rischi dell'utilizzo di antidepressivi in gravidanza: Una revisione della letteratura 80
Two-Injection Start Regimen of Long-Acting Aripiprazole in 133 Patients With Schizophrenia 78
null 77
Which mixed depression model? A comparison between DSM-5-defined mixed features and Koukopoulos' criteria 77
Interazione tra farmaci 75
Biomarkers, Inflammation, and Bipolar Disorder: Association Between the Improvement of Bipolar Disorder Severity and the Improvement in C-Reactive Protein Levels After 7 Days of Inpatient Treatment 74
null 74
Adult obsessive-compulsive disorder and quality of life outcomes: a systematic review and meta-analysis 73
Accuracy of self-assessment of real-life functioning in schizophrenia 72
Practical guidance for prescribing trazodone extended-release in major depression 67
Pharmacokinetic Interactions 66
Effectiveness and Tolerability of Supratherapeutic Dosing of Vortioxetine in Patients With Treatment-Resistant Depression 65
Principi di farmacodinamica e farmacocinetica nello switch tra antipsicotici: focus su cariprazina 65
Using sertraline in postpartum and breastfeeding: balancing risks and benefits 64
Neuroticism and conscientiousness moderate the effect of oral medication beliefs on adherence of people with mental illness during the pandemic 63
Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia 58
Development, acceptability and efficacy of a standardized healthy lifestyle intervention in recurrent depression 56
Binge eating disorder: from clinical research to clinical practice 55
Heterozygosity for Neuronal Ceroid Lipofuscinosis predisposes to Bipolar Disorder 55
Radiofrequency echographic multispectrometry (REMS): an innovative technique for the assessment of bone status in young women with anorexia nervosa 53
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 52
Totale 16.045
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.245
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020508 0 0 0 0 0 0 0 0 0 284 77 147
2020/20212.011 95 187 64 148 95 216 136 252 205 263 165 185
2021/20221.364 83 140 123 135 97 47 88 101 129 119 71 231
2022/20233.884 98 143 250 241 176 333 63 192 2.121 118 91 58
2023/20241.954 84 55 190 102 142 503 512 64 29 62 85 126
2024/20252.188 98 204 282 262 400 232 118 133 326 133 0 0
Totale 16.211